Paul Berns
InvestorUnicorn founderChairman and Chief Executive Officer at Neumora Therapeutics · Managing Director at ARCH Venture Partners · Board director at Mirador Therapeutics · Board director at Areteia Therapeutics · Board director at Metsera
Wisconsin
Writes $50K – $150M checks · typically $25M
FoundedNeumora Therapeutics$2.6B
Find your path to Paul
73 people in our graph share verified history with Paul — schools, employers, funds. One of them is your warm intro.
About
Paul Berns is a pharma operator who helped architect Humira, led Anacor (sold to Pfizer for over $5 billion), co-founded and runs Neumora, with unusually direct large-scale commercialization experience.
Likely email· guessed from name + firm domain, not firm-published
- p•••@archventure.comreveal100% confident
Invests in
AI & Machine LearningBiotechDeep TechHardwareHealthtechMedical Devices
Board director at Mirador Therapeutics
Intro paths
In turn, Paul can intro founders to Mirador Therapeutics's investors below.
Mirador Therapeutics's investors · 3
Co-founders at Mirador Therapeutics
Board director at Areteia Therapeutics
Intro paths
In turn, Paul can intro founders to Areteia Therapeutics's investors below.
Areteia Therapeutics's investors · 7
Board director at Metsera
Intro paths
In turn, Paul can intro founders to Metsera's investors below.
Metsera's investors · 7
Co-founders at Metsera
Deals · 1
Ollin Biosciences, Inc.Board seat
via ARCH Venture Partners · filed Jun 2026 · $330M raise
Attribution from SEC filings, press coverage, and firm rosters.
Other disclosed investments
Investor
Areteia TherapeuticsBlackThorn TherapeuticsElephasEpirium BioHappy HealthHI-BioKaizen Brain CenterKardiganMatter NeuroscienceMetseraTenvie
Sources: SEC Form D filings · curated public sources.
Colleagues at ARCH Venture Partners
Network1
Investors connected to Paul in public investor directories — a warm-intro map.
Frequently asked questions
- Who is Paul Berns?
- Paul Berns is a pharma operator who helped architect Humira, led Anacor (sold to Pfizer for over $5 billion), co-founded and runs Neumora, with unusually direct large-scale commercialization experience.
- Where does Paul Berns work?
- Paul Berns is Chairman and Chief Executive Officer of Neumora Therapeutics and Managing Director at ARCH Venture Partners and Board director at Mirador Therapeutics and Board director at Areteia Therapeutics and Board director at Metsera.
- What does Paul Berns invest in?
- Paul Berns invests in AI & Machine Learning, Biotech, Deep Tech, Hardware, Healthtech, Medical Devices.
- What check size does Paul Berns write?
- Paul Berns typically writes checks of $50K – $150M.
- What companies did Paul Berns found?
- Paul Berns founded Neumora Therapeutics.
- What boards does Paul Berns sit on?
- Paul Berns holds tracked board seats at Areteia Therapeutics, Elephas Biosciences, Metsera, Mirador Therapeutics, Ollin Biosciences, Inc..
- What companies has Paul Berns invested in?
- Investments tracked here include Areteia Therapeutics, BlackThorn Therapeutics, Elephas, Epirium Bio, Happy Health, HI-Bio, Kaizen Brain Center, Kardigan, Matter Neuroscience, Metsera, Ollin Biosciences, Inc., Tenvie.